HLIT's 1‑year outperformance (+41.2% vs. +17.5% for the S&P) is the standout, indicating that the company has delivered superior growth amid broader market recovery, which could justify a higher valuation multiple and support bullish investor sentiment.
The three‑year negative CAGR of -8.8% signals lingering execution risk; if upcoming product pipelines or cost controls fail to materialize, the stock could revert to underperformance, potentially eroding its long‑term premium relative to the broader market.
While institutional ownership is high, the concentration risk is notable: a single large holder reducing its stake by just 5% could trigger a sell‑off that depresses price by several percent, given the stock's thin float and elevated beta.
The most striking finding is the near‑50% YoY revenue drop combined with a still‑elevated R&D spend, which signals that Harmonic may be sacrificing short‑term earnings to protect its technology pipeline—a double‑edged sword for investors seeking both stability and future upside.
The primary margin risk is the thin operating margin of 4.7%; with revenue falling nearly half, any further cost inflation or inability to trim SG&A could push operating income into deeper loss territory, eroding cash flow and limiting financing flexibility.
The most striking profitability signal is the 186% plunge in net margin (from -4.2% to -12.0%), which directly drives the ROE decline and signals that cost structure pressures or pricing weakness are severely impairing earnings potential.
| Year | ROE% | Margin% | Turnover | Leverage | ROIC% | ROCE% | ROA% |
|---|---|---|---|---|---|---|---|
| 2025 | -11.3 | -12.0 | 0.50 | 1.87 | 4.3 | 3.3 | -6.0 |
| 2024 | 8.4 | 5.8 | 0.85 | 1.71 | 13.3 | 10.0 | 4.9 |
| 2023 | 19.2 | 13.8 | 0.79 | 1.76 | 6.2 | 4.5 | 10.9 |
| 2022 | 8.7 | 4.5 | 0.88 | 2.19 | 14.0 | 11.7 | 4.0 |
| 2021 | 4.5 | 2.6 | 0.73 | 2.34 | 4.6 | 4.0 | 1.9 |
| 2020 | -11.3 | -7.7 | 0.64 | 2.29 | -3.1 | -2.8 | -4.9 |
| 2019 | -2.3 | -1.5 | 0.69 | 2.33 | 3.7 | 3.3 | -1.0 |
| 2018 | -9.2 | -5.2 | 0.79 | 2.24 | -1.5 | -1.3 | -4.1 |
| 2017 | -38.0 | -23.2 | 0.71 | 2.33 | -21.9 | -19.4 | -16.3 |
| 2016 | -26.7 | -17.8 | 0.73 | 2.05 | -18.1 | -16.4 | -13.1 |
| 2015 | -4.8 | -4.2 | 0.72 | 1.60 | -3.0 | -2.9 | -3.0 |
The 133‑day cash conversion cycle represents a liquidity risk; if collections or inventory turnover worsen by just 10%, cash tied up would increase by roughly 13 days, tightening working‑capital buffers and potentially forcing higher short‑term borrowing.
| Year | Total Asset Days | Inventory Days | Receivables Days | Fixed Asset Days | Payables Days | Cash Conversion Cycle |
|---|---|---|---|---|---|---|
| 2025 | 727 | 89 | 87 | 40 | 43 | 133 |
| 2024 | 428 | 75 | 98 | 21 | 41 | 132 |
| 2023 | 461 | 104 | 88 | 35 | 48 | 144 |
| 2022 | 415 | 143 | 67 | 38 | 80 | 130 |
| 2021 | 499 | 105 | 70 | 53 | 95 | 80 |
| 2020 | 570 | 70 | 73 | 68 | 47 | 96 |
| 2019 | 532 | 59 | 93 | 46 | 83 | 69 |
| 2018 | 462 | 48 | 84 | 20 | 63 | 69 |
| 2017 | 518 | 50 | 71 | 30 | 64 | 57 |
| 2016 | 498 | 73 | 78 | 29 | 51 | 100 |
| 2015 | 508 | 81 | 67 | 26 | 41 | 108 |
| Year | Total Assets | Total Liabilities | Total Equity | Total Debt | Net Debt | Cash | Current Assets | Current Liabilities |
|---|---|---|---|---|---|---|---|---|
| 2025 | $718M | $335M | $383M | $148M | $24M | $124M | $494M | $198M |
| 2024 | $797M | $331M | $465M | $148M | $47M | $101M | $366M | $168M |
| 2023 | $768M | $331M | $437M | $156M | $72M | $84M | $331M | $272M |
| 2022 | $710M | $386M | $325M | $161M | $71M | $90M | $345M | $322M |
| 2021 | $694M | $397M | $297M | $190M | $57M | $133M | $323M | $224M |
| 2020 | $592M | $333M | $258M | $185M | $86M | $99M | $238M | $147M |
| 2019 | $587M | $335M | $252M | $186M | $93M | $93M | $251M | $192M |
| 2018 | $511M | $283M | $228M | $135M | $69M | $66M | $197M | $136M |
| 2017 | $508M | $290M | $218M | $132M | $75M | $57M | $172M | $142M |
| 2016 | $554M | $283M | $271M | $124M | $69M | $56M | $217M | $145M |
| 2015 | $525M | $197M | $328M | $98M | $-28M | $126M | $286M | $85M |
| Year | Operating CF | Investing CF | Financing CF | CapEx | Free Cash Flow | Buybacks | Dividends |
|---|---|---|---|---|---|---|---|
| 2025 | $108M | $-11M | $-81M | $-11M | $97M | $-79M | |
| 2024 | $62M | $-9M | $-33M | $-9M | $53M | $-30M | |
| 2023 | $7M | $-8M | $-5M | $-8M | $-1M | ||
| 2022 | $5M | $-1M | $-43M | $-9M | $-4M | $-5M | |
| 2021 | $41M | $-13M | $8M | $-13M | $28M | ||
| 2020 | $39M | $-32M | $-2M | $-32M | $7M | ||
| 2019 | $31M | $-10M | $6M | $-10M | $21M | ||
| 2018 | $12M | $-7M | $3M | $-7M | $5M | ||
| 2017 | $3M | $-4M | $1M | $-11M | $-8M | ||
| 2016 | $0M | $-70M | $-0M | $-15M | $-15M | ||
| 2015 | $6M | $-10M | $58M | $-14M | $-8M | $-73M |
This report is generated by Finexus and is provided for informational purposes only. It does not constitute investment advice, a recommendation, or an offer or solicitation to buy or sell any security.
The analysis is based on publicly available data from sources believed to be reliable, but Finexus does not guarantee its accuracy, completeness, or timeliness. Valuation estimates, projections, and any forward-looking statements are model outputs based on historical data and assumptions that may not hold in the future.
Past performance is not indicative of future results. Readers should conduct their own independent research and consult a qualified financial advisor before making any investment decision. Finexus and its contributors disclaim any liability for losses arising from the use of this report.
Created 2026-06-07 · finexus.net